We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+12.85%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$525B
AUM Growth
+$44.8B
Cap. Flow
-$12.4B
Cap. Flow %
-2.36%
Top 10 Hldgs %
23.82%
Holding
13,823
New
1,903
Increased
5,066
Reduced
5,122
Closed
1,577

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.23%
2 Technology 2.06%
3 Consumer Discretionary 1.41%
4 Healthcare 0.83%
5 Financials 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOR
11501
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$68.6K ﹤0.01%
+5,085
New +$82.4K
FEAM icon
11502
5E Advanced Materials
FEAM
$70.6M
$68.6K ﹤0.01%
+2,116
New +$103K
JT
11503
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
$68.6K ﹤0.01%
69,973
+11,658
+20% +$11.4K
DFLI icon
11504
Dragonfly Energy
DFLI
$17.1M
$68.3K ﹤0.01%
+1,401
New +$106K
POET icon
11505
POET Technologies
POET
$1.42B
$68.3K ﹤0.01%
73,006
+41,035
+128% +$71.9K
NMR icon
11506
Nomura Holdings
NMR
$29.6B
$68.2K ﹤0.01%
15,132
-5,322
-26% -$21.9K
SRTA
11507
CALL
Strata Critical Medical Inc
SRTA
$546M
$68.1K ﹤0.01%
19,300
-40,500
-68% -$116K
PIII icon
11508
P3 Health Partners
PIII
$36.7M
$68K ﹤0.01%
965
+84
+10% +$5.79K
NEON icon
11509
Neonode
NEON
$14.8M
$68K ﹤0.01%
29,703
+15,557
+110% +$22.8K
KPTI icon
11510
Karyopharm Therapeutics
KPTI
$44M
$68K ﹤0.01%
5,240
-3,947
-43% -$53.2K
BFLY icon
11511
CALL
Butterfly Network
BFLY
$2.32B
$67.9K ﹤0.01%
62,900
-65,200
-51% -$64.5K
SKYX icon
11512
SKYX Platforms
SKYX
$165M
$67.9K ﹤0.01%
42,442
-11,552
-21% -$18K
CUE icon
11513
PUT
Cue Biopharma
CUE
$205M
$67.8K ﹤0.01%
857
+70
+9% +$5K
ICL icon
11514
ICL Group
ICL
$7.32B
$67.7K ﹤0.01%
13,520
-50,575
-79% -$257K
GOL
11515
CALL
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$67.7K ﹤0.01%
18,700
-400
-2% -$1.31K
MTA
11516
PUT
Metalla Royalty & Streaming
MTA
$1.03B
$67.5K ﹤0.01%
21,900
-20,000
-48% -$59.6K
NTWK icon
11517
NetSol Technologies
NTWK
$47.7M
$67.4K ﹤0.01%
31,339
+18,199
+139% +$36.5K
LUXE
11518
CALL
LuxExperience B.V.
LUXE
$1.07B
$67.3K ﹤0.01%
+21,100
New +$65.7K
GBIO
11519
DELISTED
Generation Bio
GBIO
$67.2K ﹤0.01%
+4,075
New +$71.1K
ALYA
11520
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$66.9K ﹤0.01%
+51,058
New +$66.9K
SANW
11521
DELISTED
S&W Seed Co
SANW
$66.9K ﹤0.01%
5,028
+2,846
+130% +$36.6K
IRD
11522
Opus Genetics
IRD
$320M
$66.8K ﹤0.01%
22,205
-33,795
-60% -$99.9K
BPT
11523
CALL
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$66.7K ﹤0.01%
27,000
-71,900
-73% -$292K
LCTX icon
11524
Lineage Cell Therapeutics
LCTX
$293M
$66.6K ﹤0.01%
+61,079
New +$66.9K
WATT icon
11525
CALL
Energous
WATT
$65.4M
$66.4K ﹤0.01%
1,210
-3
-0.2% -$171

Similar funds

Jeff Yass's Q4 2023 Portfolio in Review

As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
  • Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
  • Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
  • Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
  • Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
  • Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
  • Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.